Company Search:
Advanced Search
Sponsored Links
Egypt International Pharmaceuticals Company Snapshot
Egypt International Pharmaceuticals operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Egypt International Pharmaceuticals with three other companies in this sector in Egypt: Alexandria Pharmaceuticals and Chemical Industries Co (2015 sales of 382.89 million Egyptian Pounds [US$43.12 million] ), Memphis Pharmaceutical & Chemical Industries (396.15 million Egyptian Pounds [US$44.61 million] ), and Glaxo Smith Kline (1.02 billion Egyptian Pounds [US$114.97 million] of which 100% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2015, sales at Egypt International Pharmaceuticals were 1.70 billion Egyptian Pounds (US$191.10 million). This is an increase of 7.5% versus 2014, when the company's sales were 1.58 billion Egyptian Pounds. This was the fifth consecutive year of sales increases at Egypt International Pharmaceuticals (and since 2010, sales have increased a total of 53%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Egypt International Pharmaceuticals
  Stock Performance Chart for Egypt International Pharmaceuticals
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2016): 70.26
(Figures in Egyptian Pounds)
1 Week 0.4%   13 Weeks -3.8%  
4 Weeks -9.6%   52 Weeks -11.1%  
Egypt International Pharmaceuticals Key Data:
  Ticker: PHAR Country: Egypt
  Exchanges: CAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,696,976,881
(Year Ending Jan 2016).
Employees: 2,039
  Currency: Egyptian Pounds Market Cap: 5,574,175,464
  Fiscal Yr Ends: December Shares Outstanding: 79,336,400
  Share Type: Ordinary Closely Held Shares: 39,078,912
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.